-
Annual Conference Highlights Emerging MS Treatments
Thousands of scientists, doctors, pharmaceutical company executives and others — representing about 100 countries — will meet for three days to discuss and debate the latest developments in multiple sclerosis (MS) at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, best known as ECTRIMS.
Click here to read about some of the conference’s highlights that already have people buzzing.
Do any of these ideas or presentatios have you really excited?
Sorry, there were no replies found.
Log in to reply.